| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -8.1e-05 | 1 |